340B Program Alert: HRSA Approves Manufacturer Rebate Models for Pilot Program Participation

In a move that will fundamentally change how the 340B Drug Pricing Program (“340B Program”) operates for a subset of medications, HRSA’s Office of Pharmacy Affairs (“OPA”) opted late last week to approve eight manufacturer plans for participation in the 340B Rebate Model Pilot Program (“Pilot”)….
By: Quarles & Brady LLP